Literature DB >> 15660771

Cortical resection with electrocorticography for intractable porencephaly-related partial epilepsy.

Koji Iida1, Hiroshi Otsubo, Kazunori Arita, Frederick Andermann, Andre Olivier.   

Abstract

PURPOSE: We evaluated the results of cortical resection of epileptogenic tissue for treatment of intractable porencephaly-related epilepsy.
METHODS: We examined clinical features, electrophysiological data, surgical findings, and seizure outcomes after cortical resection in eight patients with intractable epilepsy related to porencephalic cysts.
RESULTS: All eight patients had hemiparesis. Five retained motor function in the hemiparetic extremities; six retained visual fields. All had partial seizures, six with secondary generalization. Seven patients had simple and three had complex partial seizures (CPSs); two also had drop attacks. Four patients had multiple seizure types. Long-term scalp video-EEG (LVEEG) localized interictal epileptic abnormalities that anatomically corresponded to the cyst location in three patients. LVEEG recorded ictal-onset zones in five; these anatomically corresponded to the cyst location in three of the five. EEG recorded generalized seizures in two patients, hemispheric in one, and multifocal in two. Intraoperative electrocorticography (ECoG) revealed interictal epileptic areas extending beyond the margins of the cyst in seven patients. We resected ECoG-localized interictal epileptic areas completely in five patients and partially in two. Cortical resection was based on seizure semiology and LVEEG in one patient whose ECoG showed no epileptiform discharges. After a minimum follow-up of 1 year, six patients had excellent seizure outcome (Engel class I), and two had a >90% seizure reduction (Engel class III) without complications.
CONCLUSIONS: Cortical resection guided by ECoG allows preservation of motor function and visual field and provides an effective surgical procedure for treatment of intractable epilepsy secondary to porencephaly.

Entities:  

Mesh:

Year:  2005        PMID: 15660771     DOI: 10.1111/j.0013-9580.2005.28704.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  7 in total

1.  Symptomatic epilepsy in children with poroencephalic cysts secondary to perinatal middle cerebral artery occlusion.

Authors:  Francesco Guzzetta; Domenica Battaglia; Concezio Di Rocco; Massimo Caldarelli
Journal:  Childs Nerv Syst       Date:  2006-07-01       Impact factor: 1.475

2.  A micro-electrocorticography platform and deployment strategies for chronic BCI applications.

Authors:  Sanitta Thongpang; Thomas J Richner; Sarah K Brodnick; Amelia Schendel; Jiwan Kim; J Adam Wilson; Joseph Hippensteel; Lisa Krugner-Higby; Dan Moran; Azam S Ahmed; David Neimann; Karl Sillay; Justin C Williams
Journal:  Clin EEG Neurosci       Date:  2011-10       Impact factor: 1.843

3.  Surgical strategy for refractory epilepsy secondary to porencephaly: ictal SPECT may obviate the need for intracranial electroencephalography. Patient series.

Authors:  Naoki Ichikawa; Naotaka Usui; Akihiko Kondo; Takayasu Tottori; Tokito Yamaguchi; Hirowo Omatsu; Takayoshi Koike; Hiroko Ikeda; Katsumi Imai; Yukitoshi Takahashi
Journal:  J Neurosurg Case Lessons       Date:  2021-05-24

4.  Surgical outcome in neocortical resections of type IIId focal cortical dysplasia with accompanying medial temporal pathology.

Authors:  Kyriakos Garganis; Vasileios Kokkinos; Basilios Zountsas
Journal:  Epilepsy Behav Case Rep       Date:  2012-12-28

5.  Surgical histopathologic findings of 232 Chinese children cases with drug-resistant seizures.

Authors:  Yao Kun; Duan Zejun; Zhou Jian; Zhai Feng; Liu Changqing; Qi Xueling
Journal:  Brain Behav       Date:  2020-02-14       Impact factor: 2.708

6.  Porencephalic cyst in adult.

Authors:  Stefano Tambuzzi; Guendalina Gentile; Riccardo Zoja
Journal:  Autops Case Rep       Date:  2022-01-07

Review 7.  Neuropsychological features of lesion-related epilepsy in adults: an overview.

Authors:  Chris E Morrison; Luba Nakhutina
Journal:  Neuropsychol Rev       Date:  2007-10-19       Impact factor: 6.940

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.